Search

everythinglearnresearchcommunity

for

Search:↓

Adding the topical gel improved hair growth more than using minoxidil or finasteride alone.

The skin is a complex barrier for drug penetration, but understanding its structure and interactions can improve drug delivery methods.

Some herbal therapies may help with skin conditions, but more research is needed to confirm their safety and effectiveness.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

PRP and cell therapies may help with hair loss, but more research is needed.

Secretome-based therapies could improve hair growth better than current treatments.

Finasteride may cause gum problems, but stopping the drug can improve these issues.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Hair restoration surgery has advanced, focusing on natural results and may improve further with new techniques and therapies.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

Hair from balding and non-balding areas regrows similarly on mice.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

The document concludes that the discussed biological mechanisms and potential therapies are not related to hair loss or hair growth.

Nanotechnology shows promise for better drug delivery and cancer treatment.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Hormonal therapies are safe and effective for treating adult women's acne.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.